US Executives with Pfizer, Moderna say they're ramping up vaccine supplies
Coronavirus vaccines: How J&J's is different from the others
The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson.The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson.
Executives with Pfizer and Moderna said the companies are ramping up their supply of coronavirus vaccines, with shipments expected to double and possibly triple in the coming weeks, in congressional testimony Tuesday.
In aTuesday, John Young, Pfizer's chief business officer, is expected to say the company plans to increase its delivery capacity of 4 million to 5 million doses a week to more than 13 million by mid-March.
Richard Nettles, the vice president of medical affairs at Johnson & Johnson, said the company plans to have enough of their single-dose Covid-19 vaccine for 20 million Americans by the end of March.
Here's how severe weather is affecting Covid-19 vaccinations in these states
The frigid temperatures, snow and ice that have devastated parts of the country are having an impact on Covid-19 vaccinations, delaying deliveries and appointments for shots. © David Ryder/Getty Images A skier makes their way down a hill on February 13, 2021 in Seattle, Washington. A large winter storm dropped heavy snow across the region.
"We are confident in our plans to deliver 100 million single-dose vaccines to the United States during the first half of 2021, and we are continuing to partner with the U.S. government to explore all options to accelerate delivery," Nettles said in prepared remarks to the committee.
Moderna expects to double its monthly delivery capacity to 40 million doses by April,, the company's president. Moderna has so far delivered 45 million doses, Hoge's testimony says.
Young attributed the increased supply to "significant investments" Pfizer made in several manufacturing sites and other improvements.
Download thefor full coverage of the coronavirus outbreak
Vaccine Hesitancy Isn’t Just One Thing
We’re going to need a portfolio of strategies to solve it. Kolina Koltai has been studying online disinformation since 2015, with a special focus on anti-vaccine groups on Facebook. “People come into the space for a variety of reasons,” she said. “At first, it was mostly parents, more women than men, and overwhelmingly white, ranging from stay-at-home moms to people with high levels of education who wanted a naturalistic upbringing for their child.” The group didn’t initially have a political lean.
The U.S., and questions about equity in . The Biden administration said this month that it was ramping up supplies to low-income communities and people of color who have been hit hard by the virus.
The Food and Drug Administration authorized emergency use of the vaccines,and are , last year.
COVID-19 spotlights debate over pregnant women in medical trials .
"Women have a secure place along with men, an equal place along with men, in the way in which biomedical research is done. The one group that was left behind was pregnant women," bioethicist says."I don't know that I feel like being a guinea pig for it, because it's not just my body right now," Meade said.